Blockchain Registration Transaction Record

Nutriband and Kindeva Achieve Key Milestone in Opioid Safety Innovation

Nutriband and Kindeva reach a manufacturing milestone for AVERSA(TM) Fentanyl, a breakthrough in opioid safety, with a $15 price target and Outperform rating.

Nutriband and Kindeva Achieve Key Milestone in Opioid Safety Innovation

The development of AVERSA(TM) Fentanyl by Nutriband and Kindeva is a critical advancement in the fight against the opioid crisis, offering a safer alternative for pain management. This innovation not only has the potential to reduce abuse and addiction rates but also addresses a significant unmet need in healthcare, impacting patients, healthcare providers, and policymakers worldwide. The progress towards FDA approval and the positive analyst outlook underscore the importance of this breakthrough in a sector desperate for solutions.

BlockchainDetails
Contract Address0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID0xb245cc50a007275d355339926b6fbf5385273734a514c124b98e33a0a1175726
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintroamHXwj-731653cbf14511d8ebbea3007be2b104